Leon Hooftman is the Chief Medical Officer at Barinthus Biotherapeutics, bringing over 20 years of experience in international biopharmaceutical drug development. Hooftman has worked extensively in fields such as immunology, oncology, and infectious diseases, with significant contributions to the development of notable drugs including mycophenolate mofetil and rituximab. Prior to their current role, Hooftman held leadership positions at organizations such as Chroma Therapeutics, Synthon BV, and Celltech/UCB. Hooftman graduated with a Doctor of Medicine (MD) degree and continues to be actively involved in the pharmaceutical industry.
This person is not in any teams
This person is not in any offices